» Articles » PMID: 30522790

The Triglyceride to High-density Lipoprotein Cholesterol (TG/HDL-C) Ratio As a Predictor of Insulin Resistance, β-cell Function, and Diabetes in Hispanics and African Americans

Overview
Specialty Endocrinology
Date 2018 Dec 8
PMID 30522790
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The TG/HDL-C ratio is used as a marker of insulin resistance (IR) in Caucasians; however, there is limited data in other ethnic groups. We hypothesized that the TG/HDL-C ratio is associated with IR in Hispanics and African Americans (AA).

Research Design And Methods: Data from the Insulin Resistance Atherosclerosis Family Study was examined for associations between TG/HDL-C ratio and IR, β-cell function and incident diabetes in non-diabetic Hispanics (n = 872, 63% female) and AA (n = 371, 61% female). Insulin sensitivity index (S) and disposition index (DI) from frequently-sampled intravenous glucose tolerance tests were used as markers of IR and β-cell function respectively. Incident type 2 diabetes was determined by fasting glucose ≥ 126 mg/dl or initiation of anti-hyperglycemia agents over 5 year follow-up.

Results: Higher TG/HDL-C ratio was associated with IR in Hispanic and AA men and women (P < 0.0002), as well as β-cell function in Hispanic women and AA men and women (P < 0.02). TG/HDL-C predicted incident type 2 diabetes in women (area under the curves 0.703 and 0.795 for Hispanics and AA respectively).

Conclusions: Similar to Caucasians, the TG/HDL-C ratio can be used to identify IR in Hispanics and AA, and may predict type 2 diabetes in women.

Citing Articles

High-density lipoprotein cholesterol as a prognostic marker for 90-day transplant-free mortality in hepatitis B virus-related acute-on-chronic liver failure.

Shi K, Zhang Y, Li Y, Wang X, Feng Y, Wang X Front Cell Infect Microbiol. 2025; 14:1458818.

PMID: 39911493 PMC: 11794805. DOI: 10.3389/fcimb.2024.1458818.


Association between the triglyceride to high-density lipoprotein cholesterol ratio and type 2 diabetes mellitus in non-alcoholic fatty liver disease.

Bian L, Tang T, Yu Q, Tong X, Hu S, You Y Sci Rep. 2024; 14(1):31048.

PMID: 39730877 PMC: 11680680. DOI: 10.1038/s41598-024-82116-0.


Association Between Nontraditional Lipid Profiles and the Risk of Type 2 Diabetes Mellitus in Chinese Adults With Hypertension: Findings From the China Hypertension Registry Study.

Tao Y, Wang T, Zhou W, Zhu L, Yu C, Li J J Clin Hypertens (Greenwich). 2024; 27(1):e14927.

PMID: 39549245 PMC: 11771795. DOI: 10.1111/jch.14927.


Triglyceride and Glucose Index as an Optimal Predictor of Metabolic Syndrome in Lebanese Adults.

Haidar S, Mahboub N, Papandreou D, Abboud M, Rizk R Nutrients. 2024; 16(21).

PMID: 39519551 PMC: 11547298. DOI: 10.3390/nu16213718.


BMI trajectories from birth to young adulthood associate with distinct cardiometabolic profiles.

Wang G, Wei D, Merid S, Ekstrom S, Klevebro S, Hernandez-Pacheco N BMC Med. 2024; 22(1):510.

PMID: 39501285 PMC: 11539615. DOI: 10.1186/s12916-024-03741-0.


References
1.
Henkin L, Bergman R, Bowden D, Ellsworth D, Haffner S, Langefeld C . Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Ann Epidemiol. 2003; 13(4):211-7. DOI: 10.1016/s1047-2797(02)00412-x. View

2.
Wagenknecht L, Langefeld C, Scherzinger A, Norris J, Haffner S, Saad M . Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes. 2003; 52(10):2490-6. DOI: 10.2337/diabetes.52.10.2490. View

3.
Almasy L, Blangero J . Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998; 62(5):1198-211. PMC: 1377101. DOI: 10.1086/301844. View

4.
Wagenknecht L, Mayer E, Rewers M, Haffner S, SELBY J, Borok G . The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results. Ann Epidemiol. 1995; 5(6):464-72. DOI: 10.1016/1047-2797(95)00062-3. View

5.
Lorenzo C, Wagenknecht L, Rewers M, Karter A, Bergman R, Hanley A . Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care. 2010; 33(9):2098-103. PMC: 2928371. DOI: 10.2337/dc10-0165. View